A/APublished research associates this genotype with typical/baseline likelihood of Stem cell growth factor beta levels — no copies of the reported risk allele.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Stem cell growth factor beta levels.
G/GPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Stem cell growth factor beta levels compared to the general population.
American journal of human genetics · 2017 · PMID 27989323
Questions about rs4656185
What is rs4656185?
rs4656185 is a single position in the genome, in or near the F5 gene. Published research associates it with stem cell growth factor beta levels. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs4656185 linked to?
On MyGeneLog this position is linked to MIP-1b (CCL4) Levels. The research behind each link, and its sources, are set out on that condition page.
Does rs4656185 affect how medicines work?
F5 carries pharmacogenomic findings for Combined hormonal contraceptives. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.
Does having rs4656185 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs4656185 come from?
GWAS Catalog, Am J Hum Genet 2016, PMID:27989323. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.